MiR-29c inhibits HCV replication via activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells
- PMID: 35542013
- PMCID: PMC9078521
- DOI: 10.1039/c7ra12815k
MiR-29c inhibits HCV replication via activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells
Abstract
Background: MiR-29c, a member of the miR-29 family, has been recognized to play an important role in hepatitis C virus (HCV) infection. However, the underlying molecular mechanism of miR-29c involved in HCV replication is not fully understood. Methods: RT-qPCR assay was used to detect the expression pattern of miR-29c and signal transducer and activator of transcription 3 (STAT3) mRNA in JFH-1-infected Huh7 cells. HCV replication was evaluated by the expression of HCV RNA, non-structural protein 5A (NS5A) and non-structural protein 3 (NS3). Dual-Luciferase Reporter assay was applied to search for the candidate target mRNAs of miR-29c. Western blot assay was performed to detect the protein level of double-stranded RNA-dependent protein kinase R (PKR), (2'-5')-oligoadenylate synthetase (OAS) and interferon regulatory transcription factor 1 (IRF1). Results: miR-29c expression was down-regulated, and STAT3 mRNA and protein expressions were up-regulated in JFH-1-infected Huh7 cells. MiR-29c overexpression or STAT3 knockdown repressed HCV replication, while miR-29c depletion or STAT3 upregulation promoted HCV replication. Additionally, STAT3 was a direct target of miR-29c, and miR-29c suppressed STAT3 protein expression in Huh7 cells. Moreover, STAT3 overexpression reversed miR-29c-mediated suppression on HCV replication. Furthermore, the anti-miR-29c-mediated inhibitory effect on type I IFN response was abated following STAT3 knockdown. Conclusions: miR-29c might repress HCV infection via promoting type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells, offering a promising avenue for HCV treatment.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures






Similar articles
-
Effects of miR-185-5p on replication of hepatitis C virus.Open Life Sci. 2021 Aug 2;16(1):752-757. doi: 10.1515/biol-2021-0067. eCollection 2021. Open Life Sci. 2021. PMID: 34395911 Free PMC article.
-
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.World J Gastroenterol. 2017 Aug 28;23(32):5895-5903. doi: 10.3748/wjg.v23.i32.5895. World J Gastroenterol. 2017. PMID: 28932081 Free PMC article.
-
MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway.Biotechnol Lett. 2021 Jul;43(7):1357-1369. doi: 10.1007/s10529-021-03115-z. Epub 2021 Apr 1. Biotechnol Lett. 2021. PMID: 33796959
-
miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling.Yonsei Med J. 2018 Jun;59(4):511-518. doi: 10.3349/ymj.2018.59.4.511. Yonsei Med J. 2018. PMID: 29749134 Free PMC article.
-
Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5.Yonsei Med J. 2018 Dec;59(10):1181-1189. doi: 10.3349/ymj.2018.59.10.1181. Yonsei Med J. 2018. PMID: 30450852 Free PMC article.
Cited by
-
Role of microRNAs in chronic hepatitis E viral infection.Bioinformation. 2025 Feb 28;21(2):240-252. doi: 10.6026/973206300210240. eCollection 2025. Bioinformation. 2025. PMID: 40322700 Free PMC article.
-
miRNAs as Potential Biomarkers for Viral Hepatitis B and C.Viruses. 2020 Dec 14;12(12):1440. doi: 10.3390/v12121440. Viruses. 2020. PMID: 33327640 Free PMC article. Review.
-
Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis.Viruses. 2022 Aug 15;14(8):1776. doi: 10.3390/v14081776. Viruses. 2022. PMID: 36016398 Free PMC article. Review.
-
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions.MedComm (2020). 2025 Mar 8;6(3):e70121. doi: 10.1002/mco2.70121. eCollection 2025 Mar. MedComm (2020). 2025. PMID: 40060195 Free PMC article. Review.
-
Recent insights and perspectives into the role of the miRNA‑29 family in innate immunity (Review).Int J Mol Med. 2025 Mar;55(3):53. doi: 10.3892/ijmm.2025.5494. Epub 2025 Jan 31. Int J Mol Med. 2025. PMID: 39886977 Free PMC article. Review.
References
-
- Wang S. H., Yeh S. H. and Chen P. J., Hepatitis C Virus II, 2016, pp. 109–136
-
- Wakita T. Methods Mol. Biol. 2009;510:305–327. - PubMed
-
- Welzel T. Petersen J. Herzer K. Ferenci P. Gschwantler M. Cornberg M. Ingiliz P. Berg T. Spengler U. Weiland O. J. Hepatol. 2016;64:S781–S782.
-
- Horsleysilva J. L. Vargas H. E. Gastroenterol. Hepatol. 2017;48:22–31. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous